Zobrazeno 1 - 1
of 1
pro vyhledávání: '"潘岳廷"'
Autor:
Yueh-Ting Pan, 潘岳廷
105
AZD-9291(Osimertinib, TagrissoTM) is an oral, third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that has been developed by AstraZeneca for the treatment of advanced non-small cell lung cancer (NSCLC). AZD
AZD-9291(Osimertinib, TagrissoTM) is an oral, third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that has been developed by AstraZeneca for the treatment of advanced non-small cell lung cancer (NSCLC). AZD
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/q5rb9a
